as on February 3, 2026 at 4:01 pm IST
Day's Low
Day's High
7.70%
Downside
0.16%
Upside
52 Week's Low
52 Week's High
59.67%
Downside
11.63%
Upside
as on February 3, 2026 at 4:01 pm IST
Market Cap
₹105.64 Cr
Return on Equity (ROE)
0.56
PE Ratio (TTM)
-21.89
Return on capital employed (ROCE)
0.84
Industry PE ratio
39.84
Beta (LTM)
0.5
P/B Ratio
1.51
Dividend Yield
0PEG Ratio
-16.09
Quarterly Earnings Growth YOY
-142.86
EPS (TTM)
-2.5
Sector
Pharmaceuticals
Book Value
9.14
Technical Analysis
Bullish
View Technical Analysis
as on February 3, 2026 at 4:01 pm IST
Novelix Pharma in the last 5 years
Lowest (-38.24x)
January 31, 2018
Today (-21.89x)
February 2, 2026
Industry (39.84x)
February 2, 2026
Highest (-1.18x)
September 29, 2021
Today’s Price to Earnings Ratio: -21.89x
Compare market cap, revenue, PE, and other key metrics of Novelix Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 105.64 | 260.23% | 0.00 | -3 | 8 | |
| NA | 42.73 | 11.93% | 0.69 | 2 | 71 | |
| BUY | 3,419.74 | 15.73% | 0.56 | 95 | 921 | |
| NA | 5.78 | -3.51% | 0.00 | -2 | 13 | |
| NA | 489.89 | -6.91% | 0.57 | 6 | 162 |
Get share price movements and forecasts by analysts on Novelix Pharma .
Source: S&P Global Market Intelligence
Search interest for Novelix Pharmaceuticals Ltd Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Novelix Pharma .
Novelix Pharmaceuticals Ltd’s net profit fell -140.63% since last year same period to ₹0.13Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -85.71% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2012, Novelix Pharmaceuticals Ltd has declared dividend of ₹0.30 per share on 23 Jul 2012 - translating a dividend yield of 0.97%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
Price Rise
![]()
In the last 3 months, Novelix Pharma. stock has moved up by 14.1%
Best in 1 Year
![]()
In the last 1 year, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
Promoter Holding Up
![]()
Promoters have increased holdings from 52.75% to 54.82% in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 47.25% to 45.18% in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, -0.07 Cr → -0.13 Cr (in ₹), with an average decrease of 85.7% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.43 Cr → 1.3 Cr (in ₹), with an average decrease of 9.1% per quarter
| Organisation | Novelix Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Novelix Pharma share price today stands at ₹62.85 as on at the close of the market. Novelix Pharma share today touched a day high of ₹62.95 and a low of ₹58.01.
Novelix Pharma touched a 52 week high of ₹70.16 and a 52 week low of ₹25.35. Novelix Pharma share price today i.e. is closed at ₹62.85, which is -10.42% down from its 52 week high and 147.93% up from its 52 week low.
Novelix Pharma market capitalisation is ₹105.64 Cr as on .
To buy Novelix Pharma shares, you need to follow these steps:
Novelix Pharma trading volume is 5,498.00 as on . This means that 5,498.00 shares of Novelix Pharma were bought and sold on the stock market during today's trading session.